Cerebral revascularization has been practiced for more than half a century and refined with the advancement of surgical instruments, adjunctive tools and technical variation. Despite the negative results of prior randomized controlled trials, cerebral revascularization remains part of the armamentarium to treat those patients at high risk of ischemic stroke like Moyamoya disease or Moyamoya atherosclerotic syndrome for flow augmentation purpose. Besides, flow replacement bypass is also mandatory for high-risk cases of hemorrhagic stroke such as cerebral aneurysms with complex (giant, fusiform, thrombosed, dolichoectatic, dissecting) morphology. In selected patients with symptomatic ischemic event due to stenosis or occlusion of main trunks (internal carotid artery, middle cerebral artery, vertebral or basilar artery) and in whom optimal medical therapy failed, cerebral revascularization is still performed aiming to prevent recurrent events including stroke.
In this research topic, we aim to highlight cerebral revascularization for the treatment and management of stroke, including ischemic and hemorrhagic strokes, from clinical research to clinical experience.
Topics of interest include, but are not limited to:
- Clinical evidence for the effectiveness and functional outcome of novel/advanced operative techniques, like one donor-two recipient anastomosis, internal maxillary artery donor bypass, and flow self-regulating bypass, in the treatment of stroke from single or multiple centers.
- Clinical studies of intracranial-to-intracranial (in-situ, re-anastomosis, re-implantation) bypass, double-barrel STA bypass or other combined bypass modalities to manage complex aneurysms, especially for hemorrhagic stroke.
- Clinical research of indirect, direct or combined reconstruction modalities for Moyamoya disease/syndrome, chronic intracranial arterial steno-occlusive disease, or clinical investigation of acute open embolectomy with distal flow augmentation bypass, especially with respect to ischemic stroke.
- Development and application of clinical neuro-imaging studies applied to novel bypass approaches for the improvement of managing ischemic or hemorrhagic stroke.
Clinical research and literature review, preferably systematic, are welcome. Please note that Case Reports are not encouraged and should be submitted to the Research Topic "Case Report Collection 2022" within the Stroke section.
Cerebral revascularization has been practiced for more than half a century and refined with the advancement of surgical instruments, adjunctive tools and technical variation. Despite the negative results of prior randomized controlled trials, cerebral revascularization remains part of the armamentarium to treat those patients at high risk of ischemic stroke like Moyamoya disease or Moyamoya atherosclerotic syndrome for flow augmentation purpose. Besides, flow replacement bypass is also mandatory for high-risk cases of hemorrhagic stroke such as cerebral aneurysms with complex (giant, fusiform, thrombosed, dolichoectatic, dissecting) morphology. In selected patients with symptomatic ischemic event due to stenosis or occlusion of main trunks (internal carotid artery, middle cerebral artery, vertebral or basilar artery) and in whom optimal medical therapy failed, cerebral revascularization is still performed aiming to prevent recurrent events including stroke.
In this research topic, we aim to highlight cerebral revascularization for the treatment and management of stroke, including ischemic and hemorrhagic strokes, from clinical research to clinical experience.
Topics of interest include, but are not limited to:
- Clinical evidence for the effectiveness and functional outcome of novel/advanced operative techniques, like one donor-two recipient anastomosis, internal maxillary artery donor bypass, and flow self-regulating bypass, in the treatment of stroke from single or multiple centers.
- Clinical studies of intracranial-to-intracranial (in-situ, re-anastomosis, re-implantation) bypass, double-barrel STA bypass or other combined bypass modalities to manage complex aneurysms, especially for hemorrhagic stroke.
- Clinical research of indirect, direct or combined reconstruction modalities for Moyamoya disease/syndrome, chronic intracranial arterial steno-occlusive disease, or clinical investigation of acute open embolectomy with distal flow augmentation bypass, especially with respect to ischemic stroke.
- Development and application of clinical neuro-imaging studies applied to novel bypass approaches for the improvement of managing ischemic or hemorrhagic stroke.
Clinical research and literature review, preferably systematic, are welcome. Please note that Case Reports are not encouraged and should be submitted to the Research Topic "Case Report Collection 2022" within the Stroke section.
